Multidrug Efflux Pumps and Development of Therapeutic Strategies to Control Infectious Diseases

  • Kunihiko Nishino
Conference paper


Bacteria have developed various ways to resist the toxic effects of antibiotics and other drugs [1]. One of these mechanisms involves the production of enzymes that inactivate antibiotics by hydrolysis or lead to the formation of inactive derivatives [2]. A second mechanism of resistance is target alteration. Cellular targets can be altered by mutation or enzymatic modification in such a way that the affinity of the antibiotic for the target is reduced [3]. These mechanisms are all specific for a single drug or a single class of drugs. However, there are more general mechanisms of resistance in which access of the unaltered agent to the target is prevented by the barrier and active transport functions of biological membranes. The barrier cannot prevent the drugs from exerting their toxic action once they have entered the cell, and the active efflux of drugs is essential to ensure significant levels of drug resistance [4].


Efflux Pump Drug Efflux Bacterial Virulence Major Facilitator Superfamily Physiological Substrate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



I thank all my colleagues who contributed to the work discussed in this review. This study was supported by the funding program for Next Generation World-Leading Researchers from Cabinet Office, Government of Japan, and the grant-in-aid from the Uehara Memorial Foundation.


  1. 1.
    Neu HC (1992) The crisis in antibiotic resistance. Science 257:1064–1073PubMedCrossRefGoogle Scholar
  2. 2.
    Davies J (1994) Inactivation of antibiotics and the dissemination of resistance genes. Science 264:375–382PubMedCrossRefGoogle Scholar
  3. 3.
    Spratt BG (1994) Resistance to antibiotics mediated by target alterations. Science 264:388–393PubMedCrossRefGoogle Scholar
  4. 4.
    Nikaido H (1994) Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382–388PubMedCrossRefGoogle Scholar
  5. 5.
    Nishino K (2005) Bacterial multidrug exporters: insights into acquisition of multidrug resistance. Science [online publication]
  6. 6.
    Nishino K, Latifi T, Groisman EA (2006) Virulence and drug resistance roles of multidrug efflux systems of Salmonella entericaserovar Typhimurium. Mol Microbiol 59:126–141PubMedCrossRefGoogle Scholar
  7. 7.
    Nishino K, Yamaguchi A (2008) Role of xenobiotic transporters in bacterial drug resistance and virulence. IUBMB Life 60:569–574PubMedCrossRefGoogle Scholar
  8. 8.
    Nishino K, Yamaguchi A (2008) Virulence and drug resistance roles of multidrug efflux pumps in Escherichia coliand Salmonella. Biosci Microflora 27:75–85Google Scholar
  9. 9.
    Nishino K, Nikaido E, Yamaguchi A (2009) Regulation and physiological function of multidrug efflux pumps in Escherichia coliand Salmonella. Biochim Biophys Acta 1794:834–843PubMedCrossRefGoogle Scholar
  10. 10.
    Nishino K, Yamaguchi A (2001) Analysis of a complete library of putative drug transporter genes in Escherichia coli. J Bacteriol 183:5803–5812PubMedCrossRefGoogle Scholar
  11. 11.
    Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y (1997) The complete genome sequence of Escherichia coliK-12. Science 277:1453–1474PubMedCrossRefGoogle Scholar
  12. 12.
    Kobayashi N, Nishino K, Yamaguchi A (2001) Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J Bacteriol 183:5639–5644PubMedCrossRefGoogle Scholar
  13. 13.
    Kobayashi N, Nishino K, Hirata T, Yamaguchi A (2003) Membrane topology of ABC-type macrolide antibiotic exporter MacB in Escherichia coli. FEBS Lett 546:241–246PubMedCrossRefGoogle Scholar
  14. 14.
    Hirata T, Saito A, Nishino K, Tamura N, Yamaguchi A (2004) Effects of efflux transporter genes on susceptibility of Escherichia colito tigecycline (GAR-936). Antimicrob Agents Chemother 48:2179–2184PubMedCrossRefGoogle Scholar
  15. 15.
    Horiyama T, Nikaido E, Yamaguchi A, Nishino K (2011) Roles of Salmonellamultidrug efflux pumps in tigecycline resistance. J Antimicrob Chemother 66:105–110PubMedCrossRefGoogle Scholar
  16. 16.
    Cloeckaert A, Chaslus-Dancla E (2001) Mechanisms of quinolone resistance in Salmonella. Vet Res 32:291–300PubMedCrossRefGoogle Scholar
  17. 17.
    Baucheron S, Imberechts H, Chaslus-Dancla E, Cloeckaert A (2002) The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella entericaserovar typhimurium phage type DT204. Microb Drug Resist 8:281–289PubMedCrossRefGoogle Scholar
  18. 18.
    Baucheron S, Chaslus-Dancla E, Cloeckaert A (2004) Role of TolC and parCmutation in high-level fluoroquinolone resistance in Salmonella entericaserotype Typhimurium DT204. J Antimicrob Chemother 53:657–659PubMedCrossRefGoogle Scholar
  19. 19.
    Horiyama T, Yamaguchi A, Nishino K (2010) TolC dependency of multidrug efflux systems in Salmonella entericaserovar Typhimurium. J Antimicrob Chemother 65:1372–1376PubMedCrossRefGoogle Scholar
  20. 20.
    Hirakawa H, Takumi-Kobayashi A, Theisen U, Hirata T, Nishino K, Yamaguchi A (2008) AcrS/EnvR represses expression of the acrABmultidrug efflux genes in Escherichia coli. J Bacteriol 190:6276–6279PubMedCrossRefGoogle Scholar
  21. 21.
    Nishino K, Nikaido E, Yamaguchi A (2007) Regulation of multidrug efflux systems involved in multidrug and metal resistance of Salmonella entericaserovar Typhimurium. J Bacteriol 189:9066–9075PubMedCrossRefGoogle Scholar
  22. 22.
    Nikaido E, Yamaguchi A, Nishino K (2008) AcrAB multidrug efflux pump regulation in Salmonella entericaserovar Typhimurium by RamA in response to environmental signals. J Biol Chem 283:24245–24253PubMedCrossRefGoogle Scholar
  23. 23.
    Nikaido E, Shirosaka I, Yamaguchi A, Nishino K (2011) Regulation of the AcrAB multidrug efflux pump in Salmonella entericaserovar Typhimurium in response to indole and paraquat. Microbiology 157:648–655PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2012

Authors and Affiliations

  1. 1.Laboratory of Microbiology & Infectious Diseases, Institute of Scientific and Industrial ResearchOsaka UniversityIbaraki, OsakaJapan

Personalised recommendations